Literature DB >> 18505086

Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.

Anna Pryczynicz1, Katarzyna Guzińska-Ustymowicz, Andrzej Kemona, Jolanta Czyzewska.   

Abstract

BACKGROUND: The epidermal growth factor family members: EGF, EGFR and the c-erbB-2(HER-2/neu) gene product have been found to play a role in carcinomas of the stomach, liver, breast, ovary and lungs. Recent reports have indicated that they are also involved in the growth of pancreatic ductal carcinoma, its invasiveness and metastasis. PATIENTS AND METHODS: Thirty-six patients with pancreatic ductal carcinoma were analysed with respect to sex, age, histological type, malignancy grade (G), pTN status (pTN), local lymph node involvement and distant metastasis. The tumor levels of EGF, EGFR and c-erbB-2 expression were determined immunohistochemically.
RESULTS: Expression of c-erbB-2 was observed in 24/36 cases, EGF in 13/36 cases and EGFR in 18/36 cases. Overexpression of EGF and EGFR was associated with metastasis to lymph nodes and other organs. A correlation was also found between EGF expression and the presence of EGFR in the tumour. The expression of c-erbB-2 protein was not found to correlate with any parameters.
CONCLUSION: EGF and EGFR play a key role in neoplastic spread through lymph node involvement and metastasis to other organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505086

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

1.  Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.

Authors:  Zhi-Gang Chang; Jun-Min Wei; Chang-Fu Qin; Kun Hao; Xiao-Dong Tian; Kun Xie; Xue-Hai Xie; Yin-Mo Yang
Journal:  Dig Dis Sci       Date:  2012-01-21       Impact factor: 3.199

2.  Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer.

Authors:  Shadan Ali; Sanjeev Banerjee; Farah Logna; Bin Bao; Philip A Philip; Murray Korc; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

3.  IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.

Authors:  Wu-Guo Deng; John Kwon; Suhendan Ekmekcioglu; Nancy J Poindexter; Elizabeth A Grimm
Journal:  Melanoma Res       Date:  2011-02       Impact factor: 3.599

4.  Quercetin 3-O-glucoside suppresses epidermal growth factor-induced migration by inhibiting EGFR signaling in pancreatic cancer cells.

Authors:  Jungwhoi Lee; Song-I Han; Jeong-Hun Yun; Jae Hoon Kim
Journal:  Tumour Biol       Date:  2015-06-26

5.  A new drug delivery method of bispecific ligand-directed toxins, which reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer.

Authors:  Seunguk Oh; Brad J Stish; Selwyn M Vickers; Donald J Buchsbaum; Ashok K Saluja; Daniel A Vallera
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.

Authors:  Altaf Mohammed; Naveena B Janakiram; Qian Li; Venkateshwar Madka; Misty Ely; Stan Lightfoot; Howard Crawford; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2010-11

7.  Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.

Authors:  Zhimin Tong; Subhankar Chakraborty; Bokyung Sung; Pooja Koolwal; Sukhwinder Kaur; Bharat B Aggarwal; Sendurai A Mani; Robert S Bresalier; Surinder K Batra; Sushovan Guha
Journal:  Cancer       Date:  2010-12-29       Impact factor: 6.860

8.  Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.

Authors:  Jesse Gore; Imade E Imasuen-Williams; Abass M Conteh; Kelly E Craven; Monica Cheng; Murray Korc
Journal:  Cancer Lett       Date:  2016-06-03       Impact factor: 8.679

9.  African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression.

Authors:  Jacqueline Jones; Angana Mukherjee; Balasubramanyam Karanam; Melissa Davis; Jesse Jaynes; R Renee Reams; Windy Dean-Colomb; Clayton Yates
Journal:  Cancer Lett       Date:  2016-07-15       Impact factor: 8.679

10.  FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin.

Authors:  David E Joyner; Sylvia H Trang; Albert J Aboulafia; Timothy A Damron; R L Randall; R Lor Randall
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.